Expression of Circulating MicroRNAs and Myokines and Interactions with Serum Osteopontin in Type 2 Diabetic Patients with Moderate and Poor Glycemic Control: A Biochemical and Molecular Study

Table 7

Receiver operating characteristic curve analysis of adropin, irisin, osteopontin, miR-146a, and miR-144 for predicting diabetes complications in poor glycemic controlled type 2 diabetes (>8% HbA1c, ).

Variable	AUC	SE		value	Sensitivity	Specificity
miR-146a	0.91	0.51	0.72-0.98	0.001	94.5%	91.4%
miR-144	0.86	0.53	0.69-0.93	0.001	88.7%	87.8%
Adropin	0.87	0.48	0.73-0.93	0.001	82.1%	79.6%
Irisin	0.82	0.45	0.65-0.91	0.001	79.4%	76.5%
Osteopontin	0.96	0.55	0.75-0.98	0.001	89.7%	79.3%

AUC: area under the curve; SE: standard error; CI: confidence interval.